|

Arnovie101 Infusion Intravenous Clinical Trials

1 actively recruiting trial

Also known as: in vivo CAR-T

Pipeline

Early 1: 1

Top Sponsors

  • Circunited BioPharma (Shenzhen) Co., Ltd.1

Indications

  • Systemic Lupus Erythematosus1
  • Lupus1
  • Autoimmune Hemolytic Anemia, AIHA1

Other1 trial

Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B Cell-Mediated Autoimmune Diseases (SLE and AIHA)
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.